KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Change in Accured Expenses (2016 - 2026)

TherapeuticsMD filings provide 17 years of Change in Accured Expenses readings, the most recent being $434000.0 for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 58.39% to $434000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $432000.0, a 235.42% increase, with the full-year FY2025 number at $272000.0, up 127.04% from a year prior.
  • Change in Accured Expenses hit $434000.0 in Q1 2026 for TherapeuticsMD, up from -$237000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $19.1 million in Q3 2022 to a low of -$14.1 million in Q4 2022.
  • Median Change in Accured Expenses over the past 5 years was -$237000.0 (2025), compared with a mean of -$691235.3.
  • Biggest five-year swings in Change in Accured Expenses: surged 3282.27% in 2022 and later crashed 331.82% in 2025.
  • TherapeuticsMD's Change in Accured Expenses stood at -$14.1 million in 2022, then soared by 73.04% to -$3.8 million in 2023, then soared by 81.79% to -$691000.0 in 2024, then skyrocketed by 65.7% to -$237000.0 in 2025, then soared by 283.12% to $434000.0 in 2026.
  • The last three reported values for Change in Accured Expenses were $434000.0 (Q1 2026), -$237000.0 (Q4 2025), and $425000.0 (Q3 2025) per Business Quant data.